134 related articles for article (PubMed ID: 7543117)
1. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
3. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders.
Longombardo G; Ferri C; Marchi S; Costa F; Lombardini F; Vacri L; Bombardieri S; Migliorini P
Clin Immunol Immunopathol; 1998 May; 87(2):124-9. PubMed ID: 9614926
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of an anti-HCV core peptide ELISA.
Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
[TBL] [Abstract][Full Text] [Related]
5. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
6. Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system.
Buratti E; Di Michele M; Song P; Monti-Bragadin C; Scodeller EA; Baralle FE; Tisminetzky SG
Clin Diagn Lab Immunol; 1997 Mar; 4(2):117-21. PubMed ID: 9067642
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
Chien DY; Choo QL; Tabrizi A; Kuo C; McFarland J; Berger K; Lee C; Shuster JR; Nguyen T; Moyer DL
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10011-5. PubMed ID: 1279666
[TBL] [Abstract][Full Text] [Related]
8. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
[TBL] [Abstract][Full Text] [Related]
10. Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment.
Yeh CT; Han CM; Lo SY; Ou JH; Fan KD; Sheen IS; Chu CM; Liaw YF
J Clin Microbiol; 1994 Sep; 32(9):2235-41. PubMed ID: 7529251
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human immune response to potential hepatitis C viral epitopes.
Khanna A; Poduri CD; Murugan P; Kumar S; Sugunan VS; Shenoy KT; Das MR
Acta Virol; 1998 Jun; 42(3):141-5. PubMed ID: 9842443
[TBL] [Abstract][Full Text] [Related]
12. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
[TBL] [Abstract][Full Text] [Related]
13. A sensitive serodiagnosis of hepatitis C virus (HCV) infection with two non-fused peptides: comparison of antibody responses detected with a newly developed assay and a commercial second-generation test.
Sato A; Ida N; Ishikawa M; Tanahashi K; Nakamura H; Sho Y; Arima T; Kunitomo T
Microbiol Immunol; 1993; 37(4):295-304. PubMed ID: 7688847
[TBL] [Abstract][Full Text] [Related]
14. [Detection of antibodies to the nucleocapsid protein of Hepatitis C virus by immunoenzyme analysis using synthetic peptides of nucleocapsid N-terminal part].
Firsova TV; Alekseenkova TI; Shibnev VA; Froesner G; Semiletov IuA
Vopr Virusol; 2001; 46(2):21-4. PubMed ID: 11392965
[TBL] [Abstract][Full Text] [Related]
15. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
Bååth L; Widell A
Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
[No Abstract] [Full Text] [Related]
16. Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis.
Rosa C; Osborne S; Garetto F; Griva S; Rivella A; Calabresi G; Guaschino R; Bonelli F
J Virol Methods; 1995 Oct; 55(2):219-32. PubMed ID: 8537460
[TBL] [Abstract][Full Text] [Related]
17. [Spectrum of antibodies to HCV antigens in patients with different clinical patterns of chronic HCV infection].
Kruglov IV; Znoĭko OO; Ogienko OL; Ianina MV; Finogenova MP; Alekseenkova TI; Braginskiĭ DM; Kuzin SN; Sukhanova LL; Grinev AA; Selivanov NA; Doroshenko NV; Shibnev VA; Semiletov IuA
Vopr Virusol; 2002; 47(2):11-6. PubMed ID: 12046459
[TBL] [Abstract][Full Text] [Related]
18. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
[TBL] [Abstract][Full Text] [Related]
19. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens.
Ishida C; Matsumoto K; Fukada K; Matsushita K; Shiraki H; Maeda Y
J Clin Microbiol; 1993 Apr; 31(4):936-40. PubMed ID: 7681849
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
